Immune Checkpoint Inhibitor Combinations in Advanced Ovarian Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Simple Summary Immune checkpoint inhibitors (ICIs) are a promising cancer treatment; however, their effectiveness in ovarian cancer is limited when used alone. This study systematically reviewed nine phase III clinical trials involving 7381 patients to understand the performance of ICIs when combined with other therapi...